Colorectal Cancer Current Events | Colorectal Cancer News | 5
|
| Page
5 of
92 |
1836 Results |
|
|
|
Sort By:
Page Views | Date |
New technique in treating patients with liver cancer proves effective
Use of multipolar radiofrequency ablation in the treatment of colorectal liver metastases is effective and has a relatively low recurrence rate, according to a recent study conducted by researchers at Charité, Campus Benjamin Franklin in Berlin, Germany. view more (2008-04-14)
Novel biomarker for prediction of survival in colorectal carcinomas revealed
Levels of a protein called thymidylate synthase (TS) within two separate compartments of a tumor cell-the nucleus and the cytoplasm-may be critical markers predicting survival in colorectal cancer, according to a study at Yale University School of Medicine. view more (2006-09-14)
Cetuximab and irinotecan combination increases survival in metastatic colorectal cancer
A phase III trial of 1,298 colorectal cancer patients has found that a combination of the drugs cetuximab (Erbitux) and irinotecan showed a significant improvement in progression-free survival over just irinotecan alone, according to an international team of researchers. view more (2007-04-17)
Study says colorectal cancer increasing in young adults
A new study finds that in sharp contrast to the overall declining rates of colorectal cancer in the United States, incidence rates among adults younger than age 50 years are increasing. view more (2009-06-08)
No differences in survival or neonatal outcomes in pregnancy-associated colorectal cancer
In one of the first studies to examine maternal and newborn health risks and colorectal cancer, UC Davis researchers have found that women diagnosed with the disease during or shortly after their pregnancies have the same survival as women who have the disease and are not pregnant. view more (2009-02-27)
Cost-effective strategy to screen second primary colorectal cancers in cancer survivors
To suggest a feasible economic strategy for second primary colorectal cancer screening of cancer survivors in Korea, A research group constructed a decision-analytic model, compared cost-effectiveness results of cancer screening in male cancer survivors. view more (2009-07-16)
ASGE urges patients to seek a qualified endoscopist before undergoing a colonoscopy
A study released today in the Annals of Internal Medicine found that colonoscopy is associated with lower death rates from colorectal cancer, however, the procedure missed lesions more often on the right side of the colon versus the left side. view more (2008-12-17)
European authorities overlook cancer screening guidelines
European recommendations for cancer screening have yet to be officially validated, despite a consensus agreement by experts from all EU member states back in November 1999, according to a letter in this week's BMJ. This lack of European policy will lead to a continuation of inefficient opportunistic screening and will increase the risk of... view more... (2001-08-15)
Colorectal cancer
Previously, only a few genes had been associated with the formation of metastases in colorectal cancer. Now, researchers of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch and Charité - University Medicine Berlin, Germany, have identified 115 genes that are disregulated both in the primary tumor and in its metastases. view more (2009-07-01)
Researchers study new drug and indications for heated chemotherapy treatment
Studies have shown that surgery combined with Intraperitoneal Hyperthermic Chemotherapy (IPHC) can improve survival rates for select patients with peritoneal carcinoma (cancer of the lining of the abdominal cavity) that has spread from colorectal or appendix cancer. view more (2008-03-17)
New European cancer figures for 2004 - cancer experts say major efforts needed against the big four killers
There were nearly 2.9 million new cases of cancer and more than 1.7 million cancer deaths in Europe last year, according to new estimates in a report published today (Thursday 17 February) in Annals of Oncology [1]. The authors warn that the ageing of the European population means that these figures will continue to rise, even if incidence and... view more... (2005-02-14)
No insurance? No colonoscopy
John M Inadomi highlights the disparity in colorectal cancer screening (CRCS) among different socioeconomic and ethnic groups in US society in a recent review published by F1000 Medicine Reports. view more (2009-05-08)
News brief: Effects of aspirin and folic acid on inflammation markers for colorectal adenomas
Unexpectedly, inflammation markers do not appear to be involved with the chemopreventative effect of aspirin on colorectal adenomas, according to a brief communication published online October 12 in the Journal of the National Cancer Institute. view more (2009-10-13)
1 surgery better than 2 for some colorectal cancer patients
A single surgery to remove cancer from both the colon and the liver to which it has spread may be better in some cases than the current standard treatment of two separate surgeries with chemotherapy in between, according to a study led by Duke University Medical Center researchers. view more (2007-03-19)
Drop in cancer deaths tied primarily to gains in behavior and screening
Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University. view more (2008-12-03)
New method proposed for determining which patients should get treatment for colorectal cancer
A new study being presented at the American Society of Clinical Oncology meeting in Chicago (Abstract #4020), may change treatment practice in about 25 percent of patients with colon cancer and is the basis for proposed changes to the way colorectal cancers will be staged. view more (2008-05-19)
New data at ASCO show CAMPTOSAR is key to treating 1st line metastatic colorectal cancer
Data presented today at the annual meeting of the American Society of Clinical Oncology (ASCO) demonstrated that CAMPTOSAR® (irinotecan HCL injection), when given in the infusional regimen FOLFIRI , provided statistically significant longer progression free survival (PFS) compared to bolus mIFL and CapeIRI , two alternative chemotherapeutic... view more... (2006-06-06)
May supplementation of docosahexaenoic acid suppress colon tumor cell growth?
Colon cancer is one of the leading causes of death in Western countries. The role of n-3 and n-6 PUFAs in colorectal carcinoma cell growth has not been well studied. It is known that PGE2, generated from AA, is an important factor in the tumorigenesis of colorectal cancer. view more (2009-03-09)
US cancer deaths down but far too few Americans screened for colon cancer
New data revealing decreasing trends in cancer deaths in the United States overall, and in colorectal cancer deaths in particular, highlight the remarkable benefits of colorectal cancer screening tests, but the lifesaving potential of these tests is unrealized for many Americans according to experts from the American College of Gastroenterology. view more (2008-02-20)
Even in a safety net health system, colorectal cancer screening disparities remain
Colorectal cancer screening rates are much lower among those in a safety net health system compared to the national average, and the number one predictor of screening is a combination of regular visits and insurance access. view more (2009-09-08)
|
|
| Page
5 of
92 |
1836 Results |
|
|
|
Sort By:
Page Views | Date |
|
